Development of copper based drugs, radiopharmaceuticals and medical materials.

Article Details

Citation

Szymanski P, Fraczek T, Markowicz M, Mikiciuk-Olasik E

Development of copper based drugs, radiopharmaceuticals and medical materials.

Biometals. 2012 Dec;25(6):1089-112. doi: 10.1007/s10534-012-9578-y. Epub 2012 Aug 23.

PubMed ID
22914969 [ View in PubMed
]
Abstract

Copper is one of the most interesting elements for various biomedical applications. Copper compounds show vast array of biological actions, including anti-inflammatory, anti-proliferative, biocidal and other. It also offers a selection of radioisotopes, suitable for nuclear imaging and radiotherapy. Quick progress in nanotechnology opened new possibilities for design of copper based drugs and medical materials. To date, copper has not found many uses in medicine, but number of ongoing research, as well as preclinical and clinical studies, will most likely lead to many novel applications of copper in the near future.

DrugBank Data that Cites this Article

Drugs